Carasent Past Earnings Performance
Past criteria checks 0/6
Carasent's earnings have been declining at an average annual rate of -22.7%, while the Healthcare Services industry saw earnings growing at 6.7% annually. Revenues have been growing at an average rate of 37.6% per year.
Key information
-22.7%
Earnings growth rate
-15.6%
EPS growth rate
| Healthcare Services Industry Growth | 2.9% |
| Revenue growth rate | 37.6% |
| Return on equity | -5.9% |
| Net Margin | -22.3% |
| Next Earnings Update | 12 Jul 2024 |
Recent past performance updates
Recent updates
Carasent ASA's (OB:CARA) 32% Jump Shows Its Popularity With Investors
Apr 25
Calculating The Fair Value Of Carasent ASA (OB:CARA)
Dec 22Is It Too Late To Consider Buying Carasent ASA (OB:CARA)?
Nov 16Carasent's (OB:CARA) Returns On Capital Are Heading Higher
Sep 07Carasent ASA's (OB:CARA) Intrinsic Value Is Potentially 73% Above Its Share Price
May 11Is Carasent ASA (OB:CARA) Potentially Undervalued?
Mar 18Is Now The Time To Look At Buying Carasent ASA (OB:CARA)?
Nov 22Carasent's (OB:CARA) Solid Profits Have Weak Fundamentals
May 06Returns Are Gaining Momentum At Carasent (OB:CARA)
Apr 29Carasent ASA Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Feb 13There Are Reasons To Feel Uneasy About Carasent's (OB:CARA) Returns On Capital
Nov 24Calculating The Intrinsic Value Of Carasent ASA (OB:CARA)
May 23We Like These Underlying Trends At Carasent (OB:CARA)
Feb 28What Type Of Shareholders Own The Most Number of Carasent ASA (OB:CARA) Shares?
Jan 24
Revenue & Expenses BreakdownBeta
How Carasent makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 251 | -56 | 150 | 0 |
| 31 Dec 23 | 244 | -46 | 146 | 0 |
| 30 Sep 23 | 235 | -64 | 117 | 0 |
| 30 Jun 23 | 227 | -49 | 106 | 0 |
| 31 Mar 23 | 210 | 5 | 84 | 0 |
| 31 Dec 22 | 195 | 31 | 65 | 0 |
| 30 Sep 22 | 179 | 47 | 98 | 0 |
| 30 Jun 22 | 168 | 15 | 87 | 0 |
| 31 Mar 22 | 154 | 33 | 75 | 0 |
| 31 Dec 21 | 137 | 0 | 62 | 0 |
| 30 Sep 21 | 117 | -33 | 99 | 0 |
| 30 Jun 21 | 98 | -21 | 89 | 0 |
| 31 Mar 21 | 83 | -46 | 80 | 0 |
| 31 Dec 20 | 71 | -38 | 73 | 0 |
| 30 Sep 20 | 64 | -14 | 26 | 0 |
| 30 Jun 20 | 58 | -4 | 24 | 0 |
| 31 Mar 20 | 52 | 3 | 23 | 0 |
| 31 Dec 19 | 48 | 3 | 22 | 0 |
| 30 Sep 19 | 44 | 2 | 20 | 0 |
| 30 Jun 19 | 40 | 0 | 19 | 0 |
| 31 Mar 19 | 35 | -3 | 18 | 0 |
| 31 Dec 18 | 24 | -7 | 15 | 0 |
| 30 Sep 18 | 14 | 12 | 16 | 0 |
| 30 Jun 18 | 6 | 18 | 12 | 0 |
| 31 Mar 18 | 0 | 19 | 7 | 0 |
| 31 Dec 17 | 0 | 20 | 6 | 0 |
| 30 Sep 17 | 25 | 128 | -28 | 0 |
| 30 Jun 17 | 79 | 131 | -4 | 0 |
| 31 Mar 17 | 136 | 139 | 22 | 0 |
| 31 Dec 16 | 194 | 142 | 50 | 0 |
| 30 Sep 16 | 205 | 3 | 10 | 0 |
| 30 Jun 16 | 234 | 56 | 51 | 0 |
| 31 Mar 16 | 259 | 56 | 69 | 0 |
| 31 Dec 15 | 305 | 61 | 94 | 0 |
| 30 Sep 15 | 322 | -31 | 131 | 0 |
| 30 Jun 15 | 307 | -80 | 100 | 0 |
| 31 Mar 15 | 314 | -84 | 100 | 0 |
| 31 Dec 14 | 294 | -79 | 91 | 0 |
| 30 Sep 14 | 255 | 2 | 64 | 0 |
| 30 Jun 14 | 248 | 2 | 63 | 0 |
| 31 Mar 14 | 246 | 3 | 66 | 0 |
| 31 Dec 13 | 254 | 5 | 72 | 0 |
| 30 Sep 13 | 256 | 7 | 73 | 0 |
| 30 Jun 13 | 263 | 9 | 80 | 0 |
Quality Earnings: CARA is currently unprofitable.
Growing Profit Margin: CARA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CARA is unprofitable, and losses have increased over the past 5 years at a rate of 22.7% per year.
Accelerating Growth: Unable to compare CARA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CARA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (8.6%).
Return on Equity
High ROE: CARA has a negative Return on Equity (-5.92%), as it is currently unprofitable.